Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Shockwave Medical (SWAV)
NASDAQ:SWAV
Shockwave Medical (SWAV) Stock Price & Analysis
697 Followers
SWAV Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$157.00 - $334.90
Previous Close$334.75
Volume4.71M
Average Volume (3M)1.29M
Market Cap
$12.57B
Enterprise Value$12.35B
Total Cash (Recent Filing)$990.55M
Total Debt (Recent Filing)$770.61M
Price to Earnings (P/E)78.4
Beta0.89
Next Earnings
Aug 05, 2024EPS Estimate
$1.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.27
Shares Outstanding37,543,542
10 Day Avg. Volume1,440,822
30 Day Avg. Volume1,289,120
Standard Deviation0.16
R-Squared0.08
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)23.44
Price to Sales (P/S)17.21
Price to Cash Flow (P/CF)43.80
P/FCF Ratio47.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue16.91
Enterprise Value/Gross Profit19.45
Enterprise Value/Ebitda64.76
Forecast
1Y Price Target
$335.00Price Target Upside0.07% Upside
Rating ConsensusHold
Number of Analyst Covering10
Shockwave Medical News
PremiumCompany Announcements
Shockwave Medical’s Structural Shift Following Major Merger
Bulls Say, Bears Say
Bulls Say
Financial PerformanceShockwave generated adjusted EBITDA of $68.5M, surpassing both CG’s estimate of $61.6M and the Street’s $64.1M.
Mergers And AcquisitionsJohnson & Johnson announced a definitive agreement to acquire Shockwave Medical for $335 per share in cash, a transaction value worth $13.1B.
Stock ValuationPrice Target increased to $335, reflecting the proposed acquisition price by Johnson & Johnson.
Bears Say
Acquisition UncertaintyAnalysts see more downside potential for SWAV shares if a deal does not occur compared to the limited upside if it does.
Stock Rating DowngradeDowngrading SWAV shares from Outperform to Market Perform.
Valuation ConcernsConcerns are raised over applying the ABMD EBITDA multiple to SWAV which may lead to inflated valuation expectations.
---
Ownership Overview
11.79% Insiders
43.45% Mutual Funds
39.30% Other Institutional Investors
5.47% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
The estimated number of people who visited one or more of the websites owned by Shockwave Medical
Desktop Users
Mobile Users
SWAV FAQ
What was Shockwave Medical’s price range in the past 12 months?
Shockwave Medical lowest stock price was $157.00 and its highest was $334.90 in the past 12 months.
What is Shockwave Medical’s market cap?
Currently, no data Available
When is Shockwave Medical’s upcoming earnings report date?
Shockwave Medical’s upcoming earnings report date is Aug 05, 2024 which is in 14 days.
How were Shockwave Medical’s earnings last quarter?
Shockwave Medical released its earnings results on May 06, 2024. The company reported $1.44 earnings per share for the quarter, beating the consensus estimate of $0.989 by $0.451.
Is Shockwave Medical overvalued?
According to Wall Street analysts Shockwave Medical’s price is currently Undervalued.
Does Shockwave Medical pay dividends?
Shockwave Medical does not currently pay dividends.
What is Shockwave Medical’s EPS estimate?
Shockwave Medical’s EPS estimate is $1.18.
How many shares outstanding does Shockwave Medical have?
Shockwave Medical has 37,544,000 shares outstanding.
What happened to Shockwave Medical’s price movement after its last earnings report?
Shockwave Medical reported an EPS of $1.44 in its last earnings report, beating expectations of $0.989. Following the earnings report the stock price went up 0.148%.
Which hedge fund is a major shareholder of Shockwave Medical?
Among the largest hedge funds holding Shockwave Medical’s share is Gilder Gagnon Howe & Co LLC.. It holds Shockwave Medical’s shares valued at 171M.
---
Shockwave Medical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$335.00 (0.07% Upside)
$335.00 (0.07% Upside)
Blogger Sentiment
Bullish
SWAV Sentiment 90%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 91.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $121.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
15.77%
12-Months-Change
Fundamentals
Return on Equity
24.73%
Trailing 12-Months
Asset Growth
109.86%
Trailing 12-Months
Company Description
Shockwave Medical
Shockwave Medical, Inc. operates as a medical device company. It focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton in 2009 and is headquartered in Santa Clara, CA.
---
SWAV Earnings Call
Q4 2024
0:00 / 0:00
---
SWAV Revenue Breakdown
72.42% Coronary
26.61% Peripheral
0.60% Reducer
0.37% Other
---
SWAV Stock 12 Month Forecast
Average Price Target
$335.00
▲(0.07% Upside)
Technical Analysis
Best Analysts Covering SWAV
1 Year
1 Year Success Rate
8/9 ratings generated profit
1 Year Average Return
+27.96%
assigned a buy rating 4 months ago
Copying Travis Steed's trades and holding each position for 1 Year would result in 88.89% of your transactions generating a profit, with an average return of +27.96% per trade.
---